Protein analysis Protoarray

By External Press Release Author
Tuesday, 16 September, 2008


Invitrogen Corporation has launched the ProtoArray Human Protein Microarray v4.1 which enables customers to screen biological samples or labeled probe of interest against approximately 8,200 unique human proteins in as little as one day. This technology has a broad range of applications - identification of novel protein biomarkers specific for infectious diseases, cancers, and autoimmune diseases; mapping protein-protein interactions important to biochemical pathways; identification of kinase/ ubiquitin ligase substrates for target discovery and validation; antibody specificity profiling for research and therapeutic antibody development; and small molecule-protein radioligand profiling for drug candidate selection and development Invitrogen Tel: 1800 331 627 www.invitrogen.com/protoarray.

Related Articles

Potential biological targets for vascular dementia

Caused by damage to blood vessels in the brain, there is currently no approved treatment for...

Ecopha Biotech announces strategic cross-border model

To commercialise its ecopha.bio technology for a Pongamia-based bioeconomy, Australian company...

Could this 'virus-tearing' plastic film protect hospital equipment?

A thin plastic film that tears apart viruses on contact could help protect high-touch hospital...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd